Active	Status	Sponsor type	Region	Phase	Filter
1 Active 12 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Johnson, Bankole
NCT01182766: New Treatment for Alcohol and Nicotine Dependence	Active, not recruiting	2/3	294	US	Topiramate with brief behavioral enhancement therapy, Topamax, Placebo with brief behavioral enhancement therapy, sugar pill	University of Virginia, National Institute on Alcohol Abuse and Alcoholism (NIAAA), M.D. Anderson Cancer Center, University of California, San Diego	Alcohol Dependence, Nicotine Dependence	06/22	06/22

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Johnson, Bankole
NCT01182766: New Treatment for Alcohol and Nicotine Dependence	Active, not recruiting	2/3	294	US	Topiramate with brief behavioral enhancement therapy, Topamax, Placebo with brief behavioral enhancement therapy, sugar pill	University of Virginia, National Institute on Alcohol Abuse and Alcoholism (NIAAA), M.D. Anderson Cancer Center, University of California, San Diego	Alcohol Dependence, Nicotine Dependence	06/22	06/22